CD Formulation provides nucleic acid drug discovery, product characterization, process development services, and more. Our extensive experience allows us to provide innovative solutions to the specific challenges posed by your nucleic acid formulations.
CD Formulation offers professional, customized services for nucleic acid drugs, including small nucleic acids, mRNA vaccines, and tailored nucleic acid modifications. By leveraging our advanced nucleic acid design and synthesis platform, we deliver the highest quality services.
CD Formulation guarantees thorough preparation for your nucleic acid formulations. Utilizing our advanced drug delivery platform, we specialize in carrier development and optimization for nucleic acid drugs, offering the most effective delivery strategies and routes for your formulations.
CD Formulation's services encompass qualitative, quantitative, and physicochemical analyses of nucleic acids, allowing our clients to comprehensively characterize nucleic acid molecules from various perspectives.
Recognizing the significance of bioactivity analysis and efficacy evaluation in biological preparations, CD Formulation specializes in assessing the safety, immunogenicity, and both in vivo and in vitro activities of nucleic acid drugs.
Possessing extensive expertise in process development, CD Formulation implements rigorous quality control systems to provide comprehensive pilot-scale production solutions tailored to our clients' needs.
CD Formulation has been at the forefront of nucleic acid formulation for many years. Let's work together to move your program forward.
CD Formulation employs rigorous quality control protocols to ensure the integrity and efficacy of nucleic acid formulations. Our comprehensive approach includes meticulous inspection, proactive internal quality management, and continuous quality monitoring to maintain the highest standards in product excellence.